Fundz

Who to call at vTv Therapeutics Inc., and when

Fundz watches for the moments vTv Therapeutics Inc. starts buying, and tells you who to reach.

  • An alert the day vTv Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at vTv Therapeutics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at vTv Therapeutics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

vTv Therapeutics Enters Second Amendment to License Agreement with Newsoara Biopharma

Feb 02, 2026

Contract Type

licensing

High PointBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma

Description

On January 30, 2026, vTv Therapeutics LLC entered into the Second Amendment to a License Agreement with Newsoara Biopharma Co., Ltd. This amendment expands Newsoara's rights to vTv's PDE4 inhibitor, HPP737, to include all countries globally upon payment of a $20 million upfront fee. Additionally, Newsoara is obligated to pay up to $50 million in development milestones and $65 million in sales-related payments.

Quick answer

vTv Therapeutics Enters Second Amendment to License Agreement with Newsoara Biopharma (February 2, 2026). vTv Therapeutics Inc. is based in High Point, North Carolina, United States.

What agreement did vTv Therapeutics Inc. announce on February 2, 2026?
On January 30, 2026, vTv Therapeutics LLC entered into the Second Amendment to a License Agreement with Newsoara Biopharma Co., Ltd. This amendment expands Newsoara's rights to vTv's PDE4 inhibitor, HPP737, to include all countries globally upon payment of a $20 million upfront fee. Additionally, Newsoara is obligated to pay up to $50 million in development milestones and $65 million in sales-related payments.
What does vTv Therapeutics Inc. do?
vTv Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by cadisegliatin (TTP399), a potential...
Where is vTv Therapeutics Inc. based?
vTv Therapeutics Inc. is based in High Point, North Carolina, United States.

Source: Fundz verified event record.

Company Information

Company

vTv Therapeutics Inc.

Location

4170 MENDENHALL OAKS PKWY

High Point, North Carolina, United States

About

vTv Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by cadisegliatin (TTP399), a potential adjunctive therapy to insulin for the treatment of type 1 diabetes. vTv’s development partners are pursuing additional indications in type 2 diabetes, chronic obstructive pulmonary disease, renal disease, primary mitochondrial myopathy, and glioblastoma and other cancers and cancer treatment-related conditions.

Related People

Thomas
Likely contact at this company
••••••••@••••••••

See Thomas's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for vTv Therapeutics Inc.'s next move

Learn about Strategic plan

vTv Therapeutics Inc. signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.